Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023550

CHAIRMAN & CEO gave up 14,160 shares (to pay taxes)

  • CHAIRMAN & CEO acquired 29,280 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Option exercise +6,238 102,912 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Option exercise +6,481 109,393 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Option exercise +9,992 119,385 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Shares withheld for taxes −10,983 $33.49 $367,821 108,402 D
Patel Sanj K CHAIRMAN & CEO 2025-09-02 Option exercise +6,569 114,971 D
Patel Sanj K CHAIRMAN & CEO 2025-09-02 Shares withheld for taxes −3,177 $34.28 $108,908 111,794 D
Derivatives
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Grant or award · Restricted Share Unit +34,435 34,435 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Grant or award · Share Option +137,638 137,638 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Option exercise · Restricted Share Unit −6,238 18,712 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Option exercise · Restricted Share Unit −6,481 12,962 D
Patel Sanj K CHAIRMAN & CEO 2025-09-01 Option exercise · Restricted Share Unit −9,992 9,991 D
Patel Sanj K CHAIRMAN & CEO 2025-09-02 Option exercise · Restricted Share Unit −6,569 0 D
Loading xslF345X05/form4-09032025_080927.xml…